LXSN-BRCA1 gene therapy (University of Tennessee Memphis)

N/A

Report date: 2024/09/04 13:34:11

Base Information

Drug NameLXSN-BRCA1 gene therapy (University of Tennessee Memphis)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsProstatic NeoplasmsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies +[1]  N/A
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A